Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

11 Health Care Stocks Moving In Wednesday's Pre-Market Session

Author: Benzinga Insights | August 10, 2022 08:08am

 

Gainers

 

  • T2 Biosystems (NASDAQ:TTOO) shares increased by 15.45% to $0.14. The company's market cap stands at $23.9 million.
  • Infinity Pharmaceuticals (NASDAQ:INFI) shares moved upwards by 14.86% to $0.85. The market value of their outstanding shares is at $75.7 million. As per the news, the Q2 earnings report came out yesterday.
  • Aethlon Medical (NASDAQ:AEMD) shares moved upwards by 14.5% to $1.5. The market value of their outstanding shares is at $24.9 million. The company's, Q1 earnings came out yesterday.
  • Catalyst Pharmaceuticals (NASDAQ:CPRX) stock moved upwards by 12.25% to $11.9. The market value of their outstanding shares is at $1.2 billion. As per the news, the Q2 earnings report came out yesterday.
  • Codex DNA (NASDAQ:DNAY) shares rose 11.05% to $2.2. The company's market cap stands at $64.8 million. As per the press release, Q2 earnings came out yesterday.

Losers

  • OptimizeRx (NASDAQ:OPRX) stock declined by 22.7% to $17.2 during Wednesday's pre-market session. The company's market cap stands at $312.2 million. As per the press release, Q2 earnings came out yesterday.
  • Graybug Vision (NASDAQ:GRAY) shares declined by 14.53% to $1.0. The company's market cap stands at $21.3 million.
  • Berkeley Lights (NASDAQ:BLI) stock decreased by 14.47% to $4.25. The company's market cap stands at $288.3 million. As per the press release, Q2 earnings came out yesterday.
  • Akanda (NASDAQ:AKAN) shares declined by 14.4% to $1.07. The company's market cap stands at $32.9 million.
  • Vir Biotechnology (NASDAQ:VIR) shares fell 13.91% to $24.83. The market value of their outstanding shares is at $3.2 billion. As per the press release, Q2 earnings came out yesterday.
  • Evotec (NASDAQ:EVO) shares decreased by 13.38% to $12.24. The company's market cap stands at $4.3 billion. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: AEMD AKAN ARTL BLI CPRX DNAY EVO GRAY INFI OPRX TTOO VIR

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist